You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 64 No. 12, December 2007 TABLE OF CONTENTS
  Archives
  •  Online Features
  This Month in Archives of Neurology
 This Article
 •PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal

This Month in Archives of Neurology

Arch Neurol. 2007;64(12):1692-1693.

Neurology for Africa: Future Hopes

Owolabi and colleagues (SEE ARTICLE) review the current issues related to inadequate neurological care of patients in most of Africa. Increased recruitment and retention of neurologists represent a major challenge. International collaboration and support are needed to increase the number of neurologists and the resources to provide adequate care and conduct research. Editorial perspective is provided by Johan A. Aarli, MD. (SEE ARTICLE)


Vitamin A and the Brain

Tafti and Ghyselinck (SEE ARTICLE) provide a critical and clinically valuable review of the essential role that vitamin A derivatives, the retinoids, provide in synaptic plasticity, learning and memory, sleep, schizophrenia, depression, Parkinson disease, and Alzheimer disease. The clinical disorders reviewed with reference to vitamin A function are complex and involve both genetic and environmental factors.


Brain Infections in Heart Transplant Patients

Following a retrospective cohort study, van de Beek et al (SEE ARTICLE) review the infectious disease complications in 315 patients who underwent heart transplantation. Infections in the central nervous system developed in 8 patients (3%), and all presented within the first 4 years after transplantation. As reported, these infections are rare but devastating.


Pergolide and Valvular Heart Regurgitation

Corvol and colleagues (SEE ARTICLE) found that heart valve disease is independently associated with pergolide in patients with Parkinson disease and correlated with its cumulative dose (Figure).


Figure 1207FA
Figure. Relationship between risk differences and pergolide cumulative doses. Solid line indicates inverse variance regression line; dotted lines, 95% confidence intervals.



Genetics, Thymoma, and Myasthenia Gravis

Amdahl et al (SEE ARTICLE) report that specific combinations of genetic polymorphisms individually associated with myasthenia gravis synergize in predisposing to thymoma and antititin antibodies.


Hypertension and the Risk of Mild Cognitive Impairment

From a prospective, community-based cohort study, Reitz and colleagues (SEE ARTICLE) provide data indicating that a history of hypertension is related to a higher risk of mild cognitive impairment (MCI). The association is stronger with the nonamnestic than the amnestic component of MCI. Thus, these findings suggest that prevention and treatment of hypertension may have an important impact in lowering the risk of cognitive impairment.


Variability in Age at Onset Within Siblings With Familial Alzheimer Disease

Gómez-Tortosa et al (SEE ARTICLE) show that there is a wide discrepancy in age at onset of affected siblings that is not clearly explained by a single clinical variable or apolipoprotein E genotype. Maternal transmission of the disease seems to condition a more homogeneous age at onset in siblings, and the risk to develop dementia after the parent's reported age at onset decreases significantly.


Leisure Activity and Cognitive Decline in Alzheimer Disease

Greater participation in prediagnosis leisure activities, and especially intellectual activities, was associated with faster cognitive decline in a study by Helzner et al (SEE ARTICLE). These findings support the hypothesis that the disease course in Alzheimer disease may vary as a function of cognitive reserve.


Disruptive Behavior as a Predictor in Alzheimer Disease

Scarmeas and colleagues (SEE ARTICLE) provide data showing that disruptive behavior is very common in Alzheimer disease and predicts cognitive decline, functional decline, and institutionalization but not mortality.


Capgras Phenomenon and Neurodegenerative Disease

Josephs (SEE ARTICLE) reports that Capgras syndrome, characterized by a delusional belief that a person is replaced by an imposter, can be associated with neurodegenerative diseases, especially Lewy body disease. Forty-seven subjects with Capgras syndrome were evaluated, and more than 80% had a neurodegenerative disease, most commonly Lewy body disease.


Pain in Machado-Joseph Disease

França and colleagues (SEE ARTICLE) report that pain was a significant issue in patients with Machado-Joseph disease. Lower back pain was the most frequently reported location of a chronic pain syndrome. Expanded CAG repeats were higher in patients with pain.


{alpha}7 Nicotinic Receptor Up-regulation in Cholinergic Basal Forebrain Neurons in Alzheimer Disease

Counts et al (SEE ARTICLE) found that cholinergic neurons of the nucleus basalis (NB) had a significant up-regulation of {alpha}7 nicotinic acetylcholine receptor (nAChR) messenger RNA expression in subjects with Alzheimer disease compared with controls with no cognitive impairment and patients with mild cognitive impairment. {alpha}7 nAChR up-regulation may signal a compensatory response to maintain basocortical cholinergic activity during Alzheimer disease progression. Increasing NB {alpha}7 nAChR expression may serve as a marker for the progression of Alzheimer disease.







HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2007 American Medical Association. All Rights Reserved.